Sep 07, 2011
JCO has confirmed once again its position as publisher of the most important clinical oncology research, with higher scores recorded in key measures of a journal’s impact on scientific literature.
As reported by Thomson Reuters in its 2010 Journal Citation Reports®:
As reported by Thomson Reuters in its 2010 Journal Citation Reports®:
- JCO’s impact factor has increased, for the sixth year in a row, to 18.970, ranking it fourth among 184 oncology journals surveyed.
- Total 2010 citations in scientific literature exceeded 114,000, ranking JCO second among oncology journals.
- JCO’s Eigenfactor* score—a measure of the Journal’s total influence on the research community—is the 17th highest among all 8,005 Scientific, Technical, and Medical (STM) journals included in the Reports.